SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
3.920
+0.110 (2.89%)
At close: Apr 28, 2026, 4:00 PM EDT
3.750
-0.170 (-4.34%)
After-hours: Apr 28, 2026, 7:43 PM EDT
SeaStar Medical Holding Revenue
In the year 2025, SeaStar Medical Holding had annual revenue of $1.23M with 814.07% growth. SeaStar Medical Holding had revenue of $420.00K in the quarter ending December 31, 2025, with 526.87% growth.
Revenue (ttm)
$1.23M
Revenue Growth
+814.07%
P/S Ratio
12.69
Revenue / Employee
$72,588
Employees
17
Market Cap
15.66M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionICU News
- 4 weeks ago - SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026 - GlobeNewsWire
- 4 weeks ago - SeaStar Medical Holding Earnings Call Transcript: Q4 2025 - Transcripts
- 4 weeks ago - SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 weeks ago - SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026 - GlobeNewsWire
- 6 weeks ago - SeaStar Medical Holding Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 7 weeks ago - SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th - GlobeNewsWire
- 7 weeks ago - SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI - GlobeNewsWire
- 2 months ago - SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI) - GlobeNewsWire